Tradestie Institutional Equity Comparison Engine
BGM vs BHST โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BGM Overall Edge
BGM Captures Institutional Edge (1โ1 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BGM Group Ltd. Class A Ordinary Shares (BGM) driven by superior Momentum & Technical while BHST counters with relative strength in Growth & Margin. Fundamentally, BGM trades at N/M Forward P/E with -23.4% operating margin (+69.8% YoY revenue) versus BHST at N/M Forward P/E and -18.0% operating margin (+3.8% YoY). In options structure, BGM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
BGM N/M vs BHST N/M Fwd P/E
Growth & Margin Winner
BHST
Op Margin -23.4% vs -18.0% ยท YoY +69.8% vs +3.8%
Momentum & Technical Winner
BGM
1Y -17.5% vs -79.4% ยท 52W Pos 74% vs 6%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BGM
NASDAQ
BGM Group Ltd. Class A Ordinary Shares
Pharmaceutical Preparations
$8.00
-1.6% 1D
Market Cap
$108.6M
1M Return
-21.57%
1Y Return
-17.53%
Forward P/E
N/M
Unified AI Score
59.6 / 100
HOLD
Tech 65.0
Fund 55.0
Flow 50.0
Mom 50.0
BHST
NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap
$29.9M
1M Return
-22.62%
1Y Return
-79.4%
Forward P/E
N/M
Unified AI Score
58.2 / 100
HOLD
Tech 75.0
Fund 57.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BGM -17.53%
BHST -79.4%
Spread: +73.31 pp (BGM Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BGM TTM Op. Margin: -23.4%
BHST TTM Op. Margin: -18.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BGM vs BHST. Trailing 12-month operating profitability (BGM -23.4% vs BHST -18.0%) and valuation multiples (BGM N/M vs BHST N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BGM | BHST | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $108.6M | $29.9M | Larger Scale | BGM |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +69.8% | +3.8% | Higher Growth | BGM |
| Operating Margin (TTM) Profitability | -23.4% | -18.0% | Higher Margin | BHST |
| Net Profit Margin Profitability | -44.2% | -31.2% | Higher Margin | BHST |
| Return on Equity (ROE) Capital Efficiency | -7.4% | -142.5% | Higher ROE | BGM |
| 52-Week Range Position Momentum | 74% ($0โ$11) | 6% ($1โ$7) | Stronger Trend | BGM |
| Beta / 30D Volatility Risk Regime | 3.69ฮฒ ยท 80% Vol | 0.25ฮฒ ยท 86% Vol | Lower Realized Risk | BGM |
| Unified Institutional Score Composite Signal | 59.6 / 100 (HOLD) | 58.2 / 100 (HOLD) | Higher Composite | BGM |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BGM vs BHST Buy Guide
BGM
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
BHST
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BGM nor BHST registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.